Development of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes

por Polstra, Abeltje M, Goudsmit, J, Cornelissen, M
Publicado 2002

SARS Coronavirus Spike Protein Expression in HL-CZ Human Promonocytic Cells: Monoclonal Antibody and Cellular Transcriptomic Analyses

por Narasaraju, T., Soong, P. L., ter Meulen, J., Goudsmit, J., Chow, Vincent T. K.
Publicado 2009

P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study

por Maxfield, LF, King, SL, Riggs, AM, Dilan, R, LaPorte, A, Hural, J, McElrath, MJ, Goudsmit, J, Barouch, DH
Publicado 2009

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine

por Walsh, SR, Seaman, MS, Johnson, JA, Tucker, RP, Krause, KH, Weijtens, M, Pau, MG, Goudsmit, J, Dolin, R, Barouch, DH, Baden, LR
Publicado 2012

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

por Baden, LR, Dolin, R, O'Brien, KL, Abbink, P, La Porte, A, Seaman, MS, Choi, E, Tucker, R, Weitjens, M, Pau, MG, Goudsmit, J, Barouch, DH
Publicado 2009